Related Articles
Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases
Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II
Prognostic importance of DNA ploidy in non-endometrioid, high-risk endometrial carcinomas
The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II
Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary.